Mitotic kinesin inhibitors

Details for Australian Patent Application No. 2005262383 (hide)

Owner Merck & Co., Inc.

Inventors Hartman, George D.; Fraley, Mark E.

Agent Spruson & Ferguson

Pub. Number AU-A-2005262383

PCT Pub. Number WO2006/007501

Priority 60/584,804 01.07.04 US

Filing date 27 June 2005

Wipo publication date 19 January 2006

International Classifications

A61K 31/416 (2006.01) - condensed with carbocyclic ring systems, e.g. indazole

A61K 31/4155 (2006.01) - not condensed and containing further heterocyclic rings

C07D 401/12 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 403/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

Event Publications

1 February 2007 PCT application entered the National Phase

  PCT publication WO2006/007501 Priority application(s): WO2006/007501

28 January 2010 Alteration of Name

  The name of the applicant has been altered to Merck Sharp & Dohme Corp.

2 February 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005262385-Tetracyclic compounds as estrogen ligands

2005262379-Prodrugs of mitotic kinesin inhibitors